WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 172

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 324  316  309  301  294  239  188  144 
Births
Surviving infants
Pop. less than 5 years 38  38  37  37  37  34  30  24 
Pop. less than 15 years 111  110  109  108  107  96  82  67 
Female 15-49 years 88  85  83  80  78  58  43  30 

Number of reported case

(Click for retrospective incidence data for Belize)
Diphtheria
Japanese encephalitis
Measles 25  607 
Mumps
Pertussis 44  11 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Belize)
Vaccine year result method % card seen                                                
BCG 2010  98  MICS   75.3  98  98  98  99  98  96  93  71 
DTP1 2010  83  MICS   75.3  96  98  96  99  98  88 
DTP3 2010  74  MICS   75.3  98  95  96  97  94  91  91  47 
HepB_BD          99* 
HepB3 2010  74  MICS   75.3  98  95  96  97  94  76 
Hib3 2010  74  MICS   75.3  98  95  96  97  94 
JapEnc         
MCV 2010  90  MICS   75.3  96  98  98  97  96  96  86  21 
MCV2          93  98  89  92  90 
PCV1         
PCV3         
Pol3 2010  70  MICS   75.3  98  95  96  98  94  91  86  44 
Rota1         
Rota_last         
Rubella1          96  98  98  97  96 
TT2plus 2010  35  MICS   75.3  89  89  87  83  88 
PAB         
VAD1          97  83  99  97 
YFV          79  70  66 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Belize)
BCG 98  98  98  99  98  96  93  71 
DTP1 99  98  99  99  98  96  97  72 
DTP3 98  95  96  97  94  91  91  47 
HepB3 98  95  96  97  94  76 
Hib3 98  95  96  97  94 
MCV 96  98  98  97  96  96  86  21 
PAB 88  88  88  88  88  85  88 
PCV3
Pol3 98  95  96  98  94  91  86  44 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6 months; Yes contraindication to Pertussis Vaccine
DTwP 4-5 years; Yes
DTwPHibHep 2, 4, 6 months; Yes
HPV Yes From April 2014
HepB > 12 years; Yes At risk adults and children
IPV 2, 4, 6 months; 4-5 years; Yes Infants born to HIV positive mothers
Influenza 6-24 months; > 65 years; Yes and rik groups
MMR 12, 24 months; Yes
OPV 2, 4, 6 months; 4-5 years; Yes
Rabies Exposed children and adults
Td 10 years; Yes Children >7 years of age & pregnant women
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF Yes travelling to endemic countries

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  No  No  Yes  Yes 
What years does the MYP cover? number 2010-2016  2010 - 2016  2007-2011      2007 - 2011  2005-2010 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 67  100  50  83  83     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.